UNIVERSAL TECHNICAL INSTITUTE (UTI) stock: insider trades, news & valuation
Consumer Staples · Net sellingShare price and insider trades
UNIVERSAL TECHNICAL INSTITUTE insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $31.1M and 11 sold $137M of UTI stock on the open market; P/E 33.8 vs. a sector median of 22.0.
Get emailed when insiders cluster-buy stocks like UTI
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
UTI insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $335K | 6 | — | 0 |
| Q2 2026 | — | 0 | $129M | 6 |
| Q1 2026 | — | 0 | $6.1M | 8 |
| Q4 2025 | $30.8M | 6 | — | 0 |
| Q3 2025 | — | 0 | — | 0 |
| Q2 2025 | — | 0 | $1.7M | 1 |
Valuation, profit and volume
Pick score 38/100Summary
Over the past 12 months, 2 UNIVERSAL TECHNICAL INSTITUTE INC insiders reported open-market purchases totaling $31.1M, while 11 insiders reported sales totaling $137M. Among insiders with enough purchase history to measure, Coliseum Capital Management, Llc (Director) has the highest Insider Score at 92. 0 of 15 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
UTI stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 30SEC | Robert Thomas DevincenziDirector | Buy | 1,000153,330 held (+1%) | $19.68 | $20K | +4.9% | — |
| Sep 23SEC | Robert Thomas DevincenziDirector | Buy | 1,000152,330 held (+1%) | $19.83 | $20K | +4.1% | — |
| Aug 31SEC | Robert Thomas DevincenziDirector | Buy | 1,000151,330 held (+1%) | $21.80 | $22K | -5.3% | — |
| Aug 27SEC | Robert Thomas DevincenziDirector | Buy | 1,000150,330 held (+1%) | $21.77 | $22K | -5.2% | — |
| Aug 14SEC | Robert Thomas DevincenziDirector | Buy | 1,000149,330 held (+1%) | $25.95 | $26K | -20.5% | — |
| Aug 12SEC | Robert Thomas DevincenziDirector | Buy | 8,000148,330 held (+6%) | $28.21 | $226K | -26.8% | — |
| Jun 30SEC | Jerome Alan GrantCEO | Sell | 48,961335,715 held (−13%) | $41.63 | $2.0M | -50.4% | — |
| Jun 30SEC | Jerome Alan GrantCEO | Sell | 45,539384,676 held (−11%) | $41.15 | $1.9M | -49.8% | — |
| Jun 24SEC | Kevin PrehnPresident | Sell | 4,54527,025 held (−14%) | $40.00 | $182K | -48.4% | — |
| Jun 10SEC | Coliseum Capital Partners, L.P.Director | Sell | 3,000,000971,440 held (−76%) | $41.40 | $124M | -50.1% | — |
| Jun 8SEC | Christine KlinePresident | Sell | 3,50043,006 held (−8%) | $44.42 | $155K | -53.5% | — |
| May 13SEC | Linda J SrereDirector | Sell | 15,000127,564 held (−11%) | $36.59 | $549K | -43.6% | — |
| Mar 31SEC | Christopher E. KevaneGeneral Counsel | Sell | 23,65483,521 held (−22%) | $37.55 | $888K | -45.0% | — |
| Mar 18SEC | George W. BrochickDirector | Sell | 5,00027,516 held (−15%) | $36.59 | $183K | -43.6% | — |
| Mar 9SEC | Shannon Lei OkinakaDirector | Sell | 10,00019,808 held (−34%) | $34.74 | $347K | -40.6% | — |
| Mar 6SEC | Sherrell SmithEvp, Chief Academic Officer | Sell | 50,00041,219 held (−55%) | $33.84 | $1.7M | -39.0% | — |
| Mar 6SEC | Todd A HitchcockCOO | Sell | 16,500104,084 held (−14%) | $37.33 | $616K | -44.7% | — |
| Mar 4SEC | Sherrell SmithEvp, Chief Academic Officer | Sell | 30,000129,375 held (−19%) | $36.99 | $1.1M | -44.2% | — |
| Mar 4SEC | Sherrell SmithEvp, Chief Academic Officer | Sell | 22,67137,474 held (−38%) | $37.10 | $841K | -44.4% | — |
| Mar 2SEC | Jerome Alan GrantCEO | Sell | 60,040430,215 held (−12%) | $34.95 | $2.1M | -40.9% | — |
| Feb 17SEC | Carolyn Ann FrankSvp/Chief Hr Officer | Sell | 1,75030,272 held (−5%) | $30.08 | $53K | -31.4% | — |
| Dec 5SEC | Coliseum Capital Management, LlcDirector | Buy | 211,5633,779,610 held (+6%) | $25.01 | $5.3M | -17.5% | 92 |
| Dec 5SEC | Coliseum Capital Management, LlcDirector | Buy | 191,8303,971,440 held (+5%) | $25.38 | $4.9M | -18.7% | 92 |
| Dec 5SEC | Coliseum Capital Management, LlcDirector | Buy | 143,6733,568,047 held (+4%) | $24.52 | $3.5M | -15.8% | 92 |
| Dec 3SEC | Coliseum Capital Management, LlcDirector | Buy | 467,0203,424,374 held (+16%) | $24.40 | $11.4M | -15.4% | 92 |
| Dec 3SEC | Coliseum Capital Management, LlcDirector | Buy | 171,4302,887,697 held (+6%) | $23.66 | $4.1M | -12.8% | 92 |
| Dec 3SEC | Coliseum Capital Management, LlcDirector | Buy | 69,6572,957,354 held (+2%) | $24.11 | $1.7M | -14.4% | 92 |
Insiders at UNIVERSAL TECHNICAL INSTITUTE INC
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Coliseum Capital Partners, L.P.Director | — | $124M | Jun 10, 2026 | — |
| Coliseum Capital Management, LlcDirector | $30.8M | — | Dec 5, 2025 | 92 |
| Jerome Alan GrantCEO | — | $6.0M | Jun 30, 2026 | — |
| Sherrell SmithEvp, Chief Academic Officer | — | $3.6M | Mar 6, 2026 | — |
| Robert Thomas DevincenziDirector | $335K | — | Sep 30, 2026 | — |
| Christopher E. KevaneGeneral Counsel | — | $888K | Mar 31, 2026 | — |
| Todd A HitchcockCOO | — | $616K | Mar 6, 2026 | — |
| Linda J SrereDirector | — | $549K | May 13, 2026 | — |
| Shannon Lei OkinakaDirector | — | $347K | Mar 9, 2026 | — |
| George W. BrochickDirector | — | $183K | Mar 18, 2026 | — |
| Kevin PrehnPresident | — | $182K | Jun 24, 2026 | — |
| Christine KlinePresident | — | $155K | Jun 8, 2026 | — |
| Carolyn Ann FrankSvp/Chief Hr Officer | — | $53K | Feb 17, 2026 | — |
Insider activity at other Consumer Staples companies
Same sector, ranked by insider buying in the last 90 days.
UTI stock: common questions
Are UNIVERSAL TECHNICAL INSTITUTE INC insiders buying UTI stock?
In the past 12 months, 2 insiders reported open-market purchases of UTI worth $31.1M. The latest was Director Robert Thomas Devincenzi bought $20K of UTI at $19.68.
Are UNIVERSAL TECHNICAL INSTITUTE INC insiders selling UTI stock?
11 insiders reported sales worth $137M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is UTI's P/E ratio?
UTI trades at about 33.8 times trailing earnings, compared with a median of 22.0 for the Consumer Staples sector.
What is UTI's 52-week range?
Over the past year UTI has traded between $18.47 and $51.20. It last closed at $20.64 on Oct 9, 2026.